Word

TRUVESIC

Status

Pending

Status Code

686

Status Date

Tuesday, April 9, 2024

Serial Number

97939159

Mark Type

4000

Filing Date

Tuesday, May 16, 2023

Published for Opposition

Tuesday, April 9, 2024

Trademark Owner History

CG Oncology, Inc. - Owner At Publication

Classifications

5 Pharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

Trademark Events

Apr 9, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 9, 2024

Published For Opposition

Mar 20, 2024

Notification Of Notice Of Publication E-Mailed

Mar 4, 2024

Approved For Pub - Principal Register

Feb 16, 2024

Teas/Email Correspondence Entered

Feb 16, 2024

Correspondence Received In Law Office

Feb 16, 2024

Teas Response To Office Action Received

Feb 14, 2024

Notification Of Non-Final Action E-Mailed

Feb 14, 2024

Non-Final Action E-Mailed

Feb 14, 2024

Non-Final Action Written

Feb 8, 2024

Assigned To Examiner

Jun 15, 2023

New Application Office Supplied Data Entered

May 19, 2023

New Application Entered